Prior to joining OxyBand, Mr Postel was the director of process engineering and integration at dpiX.
Mr Postel has served on an NIH review committee on infectious diseases and microbiology for the past several years. He has also worked with other Silicon Valley start-ups of various stages in developing technology.
Amie Franklin, CEO of OxyBand, said: “We are very pleased Olivier has joined our team and we hope to capitalize on his expertise in therapeutic gas science and technology, and product development to enter the market quickly.”